Quality Use Of Respiratory Medicines Group 1

1. ARIA-EAACI care pathways for allergen immunotherapy in respiratory allergy
2. Patient-centered digital biomarkers for allergic respiratory diseases and asthma: The ARIA-EAACI approach – ARIA-EAACI Task Force Report
3. Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA-MeDALL hypothesis
1